| Literature DB >> 34363933 |
Ayushi Sharma1, Samarth Kansara2, Mehul Mahajan3, Bhupender Yadav2, Manoj Garg4, Amit Kumar Pandey5.
Abstract
Long noncoding RNAs (lncRNAs) regulate various hallmarks associated with the progression of human cancers through their binding with RNA, DNA, and proteins. Epithelial-Mesenchymal Transition (EMT) is a cardinal and multi-stage process where epithelial cells acquire a mesenchymal-like phenotype that is instrumental for tumor cells to initiate invasion and metastasis. LncRNAs can potentially promote tumor onset and progression as well as drug resistance by directly or indirectly altering the EMT program. Head and neck squamous cell carcinoma (HNSCC) are a dreadful malignancy affecting public health globally. The past few years have provided a better insight into the mechanism of EMT in HNSCC. The differential expression of the lncRNAs that can act either as promoters or suppressors in the process of EMT is of great importance. In this review, we aim to sum up, the highly structured mechanism with the diverse role of lncRNAs and their interaction with different molecules in the regulation of EMT. Moreover, discussing principal EMT pathways modulated by lncRNAs and their prospective potential value as therapeutic targets.Entities:
Keywords: Cisplatin resistance; Long noncoding RNAs (lncRNA); Metastasis; Tumor immunity; Upstream regulators
Mesh:
Substances:
Year: 2021 PMID: 34363933 DOI: 10.1016/j.bbadis.2021.166240
Source DB: PubMed Journal: Biochim Biophys Acta Mol Basis Dis ISSN: 0925-4439 Impact factor: 5.187